Clinical Trials Browser

Interventional × Midazolam × Gastrointestinal × Clear all

NCT04557449 2025-10-01

CDK4i

Phase 2 Active not recruiting

BreastGastrointestinalGenitourinarySarcomaThoracic

Adenocarcinoma of Lung, Breast Neoplasms, Liposarcoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

Phase 2 Completed

Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

NCT04908176 2024-12-13

A Drug-drug Interaction Study of Avapritinib and Midazolam

Phase 1 Completed

CNSGastrointestinalSarcoma

Glioblastoma, Neoplasms, Recurrence, Gastrointestinal Stromal Tumors

NCT01488045 2023-05-23

Compare Propofol to Fentanyl and Midazolam for Colonoscopy

Phase NA Completed

289 enrolled 10 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Diverticulosis, Colonic

NCT02857270 2022-11-22

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Phase 1 Completed

DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

NCT02937506 2017-12-26

Patient Satisfaction With Propofol for Out Patient Colonoscopy

Phase 4 Completed

600 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Polyps, Patient Satisfaction

NCT01402089 2016-02-02

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Phase 4 Completed

GastrointestinalGenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Gastrointestinal Stromal Tumors